First-Line IO Combo Promising in mCRC

(MedPage Today) -- The CheckMate 142 trial was presented at the 2020 American Society of Clinical Oncology (ASCO) virtual scientific meeting, exploring an immunotherapy treatment combination in patients with metastatic colorectal cancer whose tumors...